Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of PARP1 in neurodegenerative diseases and aging

18 Jan 2021

Abstract excerpt

Neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD), are characterized by progressive memory loss and motor impairment. Aging is a major risk factor for neurodegenerative diseases. Neurodegenerative diseases and aging often develop in an irreversible manner and cause a significant socioeconomic burden. When considering their pathogenesis, many studies usually focus on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcium signaling and nucleotide metabolism
Share to PARP inhibition in cancer therapy
Share to Sirtuins and Resveratrol in Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33460497
DOI: 10.1111/febs.15716

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of PARP1 in neurodegenerative diseases and agingPMID 33460497Read ↗

Pleiotropic Cellular Functions of PARP1 in Longevity and Aging: Genome Maintenance Meets InflammationSemantic proximity Read ↗

The molecular mechanism of aging and the role in neurodegenerative diseasesSemantic proximity Read ↗

Poly (ADP-ribose) polymerase 1 and neurodegenerative diseases: Past, present, and futureSemantic proximity Read ↗

Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunitiesSemantic proximity Read ↗

Systematic review on nine hallmarks of neurodegenerative diseaseSemantic proximity Read ↗

Mitochondrial Damage and Autophagy Dysregulation in Alzheimer’s Disease: Mechanisms and Therapeutic OpportunitiesSemantic proximity Read ↗

MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative DiseasesSemantic proximity Read ↗

Poly(ADP-ribose) Polymerase 1 Deficiency Attenuates Amyloid Pathology, Neurodegeneration, and Cognitive Decline in a Familial Alzheimer’s Disease ModelSemantic proximity Read ↗

Review of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases.Semantic proximity Read ↗

SIRT1 and SIRT2 Activity Control in Neurodegenerative DiseasesSemantic proximity Read ↗

Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1Semantic proximity Read ↗

SIRT1 as a therapeutic target for Alzheimer’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.